Viruses: respiratory

Influenza viruses

Influenza A (including subtypes H1N1-2009 and H3); Influenza B; Influenza C

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

RNA viruses that cause seasonal epidemics. Influenza A subtypes (H1N1 and H3N2) and influenza B cause most illness; influenza C usually causes mild infection.

Infections

Influenza; viral pneumonia; secondary bacterial pneumonia; exacerbation of heart and lung disease.

Signs and symptoms

Abrupt fever, chills, muscle aches, headache, sore throat, dry cough and fatigue; older adults may present with weakness or worsening chronic illness rather than fever.

Antibiotic and antimicrobial resistance

Antiviral resistance (for example to oseltamivir) is monitored nationally and is currently uncommon.

Treatment considerations

Antivirals (oseltamivir, baloxavir, zanamivir or peramivir) are recommended for hospitalized and high-risk patients, ideally started early; long-term care outbreaks call for treatment and antiviral prophylaxis per CDC guidance.

Infection control and public health

Droplet precautions; annual vaccination; outbreak management in long-term care.

Influenza virus particles, negatively stained transmission electron micrograph
Influenza virus particles (recreated 1918 strain), transmission electron micrograph. CDC (C. Goldsmith); public domain. Image source
Enveloped virus, schematic
Enveloped virus. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Influenza (flu).
  2. CDC. Influenza antiviral medications: summary for clinicians.
  3. IDSA. Seasonal Influenza guideline.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.